IP Library Granted Patent US 6,869,411
Granted Patent B2
US 6,869,411 · App. 10/699,358 · Granted Mar 22, 2005

Apparatus for producing blood component products

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,869,411
App. No.
10/699,358
Granted
Mar 22, 2005
Kind
B2
Abstract

A method and apparatus for producing blood component products. In one embodiment, a plurality of a predetermined type of blood component is harvested from a source of whole blood. At least two on-line yield determination techniques are utilized to determine the yield for the harvested blood components. One is a predetermined yield prediction technique and the second is a predetermined yield monitoring technique, each of which are individually calibrated in relation to a predetermined off-line yield determination technique. The predetermined yield prediction and monitoring techniques each provide the yield for the harvested blood components and each is then utilized to provide a determined yield. Consequently, when the harvested blood components are packaged the determined yield my be associated therewith, thereby providing a blood component product.

Claims (6)

1. A system for providing a blood component product, comprising:

a blood component collection device;

a blood component yield predictor associated with said blood component collection device; and

means for calibrating said blood component yield predictor to a blood component yield counter, said blood component yield counter providing blood component yield determination capabilities, wherein a predicted yield value, generated by said blood component yield predictor from a blood component collection procedure in which a blood component collection is provided by said blood component collection device, is adjusted to an adjusted predicted yield value, and wherein a blood component yield associated with said blood component collection to define a blood component product is based on said adjusted predicted yield value.

2. A system, as claimed in claim 1 , wherein said blood component collection device comprises a centrifuge.

3. A system, as claimed in claim 1 , wherein said blood component yield predictor comprises a processor, a primary yield prediction algorithm which generates said adjusted predicted yield value, and a plurality of ancillary yield prediction algorithms which provide information used by said primary yield prediction algorithm.

Assignments (7)
CHANGE OF NAME Recorded Feb 7, 2012
From: CARIDIANBCT, INC.
To: TERUMO BCT, INC.
Reel/Frame 027668/0072 →
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
To: CARIDIANBCT, INC.
Reel/Frame 026209/0890 →
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
To: GAMBRO, INC.
Reel/Frame 026209/0914 →
CHANGE OF NAME Recorded Jul 28, 2008
From: GAMBRO BCT, INC.
To: CARIDIANBCT, INC.
Reel/Frame 021301/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2007
From: GAMBRO, INC.
To: GAMBRO BCT, INC.
Reel/Frame 018787/0264 →
SECURITY AGREEMENT Recorded Nov 29, 2006
From: GAMBRO, INC.
To: CITICORP TRUSTEE COMPANY LIMITED, AS SECURITY AGENT
Reel/Frame 018552/0717 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2003
From: LANGLEY, ROBERT WARNER; DUMONT, LARRY JOE
To: GAMBRO, INC.
Reel/Frame 014667/0377 →